NNOX vs LNTH vs PHG Stock Comparison

Nano-X Imaging, Lantheus Holdings and Koninklijke Philips Prices as of Nov 3, 2026 Peers: Industry group
1 more company in this comparison (HTFL) Create a free account to keep reading and compare up to 10 companies.
NNOX Nano-X Imaging Ltd.
$0.31 -51.6% 1M -90.9% 1Y
Market cap
$18.38M
P/E
–
Revenue (TTM)
$15.63M
Div. yield
–
Diagnostic Equipment Healthcare
LNTH Lantheus Holdings, Inc.
$100.80 +0.8% 1M +77.4% 1Y
Market cap
$6.60B
P/E
24.0x
Revenue (TTM)
$1.56B
Div. yield
–
Diagnostic Equipment Healthcare
5 wins
PHG Koninklijke Philips Nv
$28.47 +19.0% 1M +4.6% 1Y
Market cap
$29.42B
P/E
15.4x
Revenue (TTM)
$30.13B
Div. yield
–
Diagnostic Equipment Healthcare
6 wins

Head to Head

11 decided of 12

Koninklijke Philips leads on 6 of the 12 questions below (Koninklijke Philips 6, Lantheus Holdings 5). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionNNOXLNTHPHGLeader
Larger companyMarket capitalisation $18.38M $6.60B $29.42B PHG
Cheaper on earningsLower P/E, profitable companies only -0.2x 24.0x 15.4x PHG
Cheaper on forward earningsLower price / next fiscal year consensus EPS — 17.5x 14.4x PHG
Faster revenue growthRevenue growth, trailing twelve months +31.5% +2.3% +53.4% PHG
More profitableNet margin, trailing twelve months -747.2% 17.7% 6.3% LNTH
Better return on capitalReturn on invested capital -116.9% 12.5% 12.4% LNTH
Less leveragedLower net debt / EBITDA 0.3x -0.1x 1.4x LNTH
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months -90.9% +77.4% +4.6% LNTH
Better 5-year returnAnnualised price return, 5 years -59.0%/yr +29.6%/yr -9.6%/yr LNTH
Less volatileAnnualised volatility, 1 year 105.9% 31.9% 28.5% PHG
Higher overall scoreMean of the five percentile scores vs peers 36/100 80/100 80/100 PHG

Percentile Scorecard

NNOXLNTHPHG

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisNNOXLNTHPHG
Valuation 53 #108 of 229 80 #46 of 229 98 #6 of 229
Growth 11 #198 of 221 63 #83 of 221 99 #4 of 221
Profitability 9 #190 of 209 95 #12 of 209 92 #17 of 209
Financial Health 72 #69 of 240 71 #71 of 240 36 #155 of 240
Shareholder Returns – 94 #10 of 147 78 #33 of 147
Overall 36 80 80
  • NNOX ranked among 248 companies in Medical Devices and Diagnostics
  • LNTH ranked among 248 companies in Medical Devices and Diagnostics
  • PHG ranked among 248 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodNNOXLNTHPHGSPY
1 month -51.6%+0.8%+19.0% -2.0%
3 months -71.0%-0.3%+7.6% -2.2%
6 months -82.7%+17.5%+7.6% +4.2%
Year to date -88.9%+51.5%+5.1% +10.6%
1 year -90.9%+77.4%+4.6% +10.4%
3 years -94.9%+56.7%+38.5% +73.6%
3 years, per year -63.0%+16.2%+11.5% +20.2%
5 years -98.8%+265.9%-39.7% +61.6%
5 years, per year -59.0%+29.6%-9.6% +10.1%
10 years —+1,072.1%-2.8% +261.3%
10 years, per year —+27.9%-0.3% +13.7%

Risk

MeasureNNOXLNTHPHGSPY
Volatility, 1Y 105.9%31.9%28.5% 12.8%
Downside volatility, 1Y 117.3%27.3%27.8% 12.8%
Beta vs S&P 500, 1Y 1.320.570.80 1.00
Return / volatility, 1Y -0.862.430.16 0.81
Max drawdown, 5Y -98.9%-59.5%-75.6% -25.4%
From 52-week high -93.2%-9.1%-13.5% -3.2%
52-week high $4.55$110.94$32.91 $779.14
52-week low $0.30$50.69$23.81 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleNNOXLNTHPHG
P/E now vs peer median -0.2xmedian 28.1x 23.9xmedian 28.1x 14.2xmedian 28.1x
P/S now vs peer median 1.4xmedian 2.9x 4.2xmedian 2.9x 0.9xmedian 2.9x
EV/EBITDA now vs peer median 0.1xmedian 18.0x 16.6xmedian 18.0x 7.9xmedian 18.0x
P/FCF now vs peer median -0.4xmedian 24.8x 17.0xmedian 24.8x 5.2xmedian 24.8x
P/B now vs peer median 0.3xmedian 2.3x 5.0xmedian 2.3x 2.1xmedian 2.3x
PEG now vs peer median -0.07median 0.95 0.23median 0.95 0.20median 0.95

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsNNOXLNTHPHG
Revenue $15.63M $1.56B $30.13B
Gross profit -$52.76M $936.02M $16.13B
Operating income -$119.69M $302.34M $2.79B
Net income -$116.81M $275.31M $1.45B
Free cash flow -$52.09M $387.83M $5.23B
R&D $18.93M $173.09M $1.99B
EPS (diluted) $-1.80 $4.08 $1.98
Cash & equivalents $31.02M $593.30M $3.12B
Total debt $3.00M $571.05M $9.23B
Shares (diluted) 64.79M 67.52M 962.50M
Enterprise value -$162.43M $4.76B $17.69B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricNNOXLNTHPHG
P/E -0.2x 23.9x 14.2x
P/FCF -0.4x 17.0x 5.2x
P/Operating cash flow -0.5x 15.9x 7.7x
P/S 1.4x 4.2x 0.9x
P/B 0.3x 5.0x 2.1x
P/Tangible book 0.4x 10.6x 2.7x
EV/EBITDA 0.1x 16.6x 7.9x
EV/EBIT 0.1x 21.7x 12.0x
EV/Revenue -0.4x 4.2x 1.1x
EV/FCF 0.1x 16.9x 6.4x
EV/Operating cash flow 0.1x 15.9x 9.4x
PEG (3Y EPS CAGR) -0.07 0.23 0.20

Growth

14 metrics
MetricNNOXLNTHPHG
Revenue growth (1Y) 31.5% 2.3% 53.4%
Revenue CAGR (3Y) 17.7% 11.4% 15.1%
Gross profit growth (1Y) -340.0% -3.4% 76.3%
Gross profit CAGR (3Y) -101.8% 16.3% 4.0%
Operating income growth (1Y) -107.4% -30.9% 49.6%
Operating income CAGR (3Y) -5.0% 118.8% 337.8%
Net income growth (1Y) -109.9% 1.6% 444.3%
Net income CAGR (3Y) -4.9% 102.1% 45.2%
EPS growth (1Y) -90.0% 5.8% 177.7%
EPS CAGR (3Y) 2.3% 105.5% 69.9%
Operating cash flow growth (1Y) -21.9% -21.7% 154.0%
Operating cash flow CAGR (3Y) -2.7% 14.5% 34.9%
Free cash flow growth (1Y) -19.4% -10.1% 74.5%
Free cash flow CAGR (3Y) 1.3% 103.0% 35.7%

Profitability

14 metrics
MetricNNOXLNTHPHG
Gross margin -337.5% 60.1% 53.5%
EBITDA margin -692.4% 25.4% 14.1%
Operating margin -765.6% 19.4% 9.2%
Pretax margin -758.5% 23.3% 8.7%
Net margin -747.2% 17.7% 6.3%
FCF margin -333.2% 24.9% 17.4%
Operating cash flow margin -298.7% 26.5% 11.8%
Return on equity -117.5% 21.8% 13.2%
Return on assets -98.6% 11.6% 5.5%
Return on invested capital -116.9% 12.5% 12.4%
Return on capital employed -114.2% 14.8% 12.6%
Asset turnover 0.1x 0.7x 1.0x
Cash conversion (OCF / net income) 0.4x 1.5x 2.4x
Stock comp / revenue 34.9% 5.0% 0.5%

Financial Health

11 metrics
MetricNNOXLNTHPHG
Debt / assets 3.3% 23.6% 29.0%
Debt / equity 0.0x 0.4x 0.7x
Net debt / EBITDA 0.3x -0.1x 1.4x
Debt / FCF -0.1x 1.5x 1.8x
Liabilities / assets 20.5% 45.7% 58.7%
Equity / assets 79.5% 54.3% 41.3%
Interest coverage – 15.3x 6.5x
Current ratio 2.8x 3.1x 1.3x
Quick ratio 2.4x 2.8x 0.8x
Cash ratio 2.3x 1.8x 0.4x
Altman Z-score -11.10 5.49 –

Shareholder Returns

7 metrics
MetricNNOXLNTHPHG
Dividend yield – – 3.5%
Net buyback yield – 2.8% -0.8%
Shareholder yield – 2.8% 2.7%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusNNOXLNTHPHG
Forward P/E – 17.5xFY2026 14.4xFY2026
EPS, next fiscal year $-1.31FY2026 $5.76FY2026 $1.98FY2026
EPS growth, next FY – -5.3%FY2026 +6.5%FY2026
EPS growth, the year after – +4.2% -10.1%
Revenue, next fiscal year $18.64MFY2026 $1.57BFY2026 $21.63BFY2026
Revenue growth, next FY +43.2%FY2026 +1.8%FY2026 +1.8%FY2026
Revenue growth, the year after +59.6% +12.7% -8.2%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersNNOXLNTHPHG
Held by institutions 15.0% 100.0% 5.4%
Institutions holding 103 468 365
Change in shares held, QoQ -46.0% +3.4% +0.8%
Institutions buying 55 249 268
Institutions selling 28 143 76
Buyers to sellers 1.96 1.74 3.53

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

NNOXLNTHPHG
NNOX 1.00 0.05 0.08
LNTH 0.05 1.00 0.19
PHG 0.08 0.19 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, NNOX, LNTH and PHG?

Koninklijke Philips (PHG) is the largest by market capitalisation: Nano-X Imaging (NNOX) $18.38M, Lantheus Holdings (LNTH) $6.60B, Koninklijke Philips (PHG) $29.42B.

Which stock is cheaper, NNOX, LNTH and PHG?

Koninklijke Philips (PHG) trades on the lowest price-to-earnings ratio (Nano-X Imaging (NNOX) -0.2x, Lantheus Holdings (LNTH) 24.0x, Koninklijke Philips (PHG) 15.4x). On next year's consensus earnings, Koninklijke Philips (PHG) is cheapest (Lantheus Holdings (LNTH) 17.5x, Koninklijke Philips (PHG) 14.4x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Koninklijke Philips (PHG) grew revenue fastest over the trailing twelve months: Nano-X Imaging (NNOX) +31.5%, Lantheus Holdings (LNTH) +2.3%, Koninklijke Philips (PHG) +53.4%.

Which company is more profitable?

Lantheus Holdings (LNTH) has the highest net margin (Nano-X Imaging (NNOX) -747.2%, Lantheus Holdings (LNTH) 17.7%, Koninklijke Philips (PHG) 6.3%). On return on invested capital, Lantheus Holdings (LNTH) leads (Nano-X Imaging (NNOX) -116.9%, Lantheus Holdings (LNTH) 12.5%, Koninklijke Philips (PHG) 12.4%).

Which stock has performed better?

Over the past year Lantheus Holdings (LNTH) returned the most: Nano-X Imaging (NNOX) -90.9%, Lantheus Holdings (LNTH) +77.4%, Koninklijke Philips (PHG) +4.6%. Over five years, Lantheus Holdings (LNTH) compounded fastest (Nano-X Imaging (NNOX) -59.0%/yr, Lantheus Holdings (LNTH) +29.6%/yr, Koninklijke Philips (PHG) -9.6%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Koninklijke Philips (PHG) has been the steadiest (Nano-X Imaging (NNOX) 105.9%, Lantheus Holdings (LNTH) 31.9%, Koninklijke Philips (PHG) 28.5%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, NNOX, LNTH and PHG?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Koninklijke Philips (PHG) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.